Imagene was founded with a clear mission to leverage AI to profile, within minutes, a broad range of biomarkers from a digitized biopsy image alone. By doing so we can overcome economical, logistical, and technological barriers to reach the full potential of precision medicine for all cancer patients. Imagene's technology classifies patterns that cannot be seen by the human eye, evolving genomics, proteomics, and spatial insights resulting in a fast and accurate molecular profiling. Our technology also enables better stratification of patients for clinical trials and the discovery of novel targets for new drugs. We are a diverse startup with bright, passionate and most of all fun team. Our success derives from our cutting-edge technology and talented multidisciplinary team of data scientists, biologists, software engineers, and medical experts. Imagene collaborates with top-tier medical centers and pharmaceutical companies worldwide, we were selected for The Marker’s ‘Most Promising Start-Ups for 2022’, and named 'Oncology Innovation of the Year' by BioTech Breakthrough Awards. The fight against cancer is profound and the world needs talented and innovative people - If you are looking for a meaningful and challenging job – Join Us!